FindTrial
Sign In

A prospective, randomized, double-blind, controlled clinical trial for observation of postoperative sleep quality in patients undergoing laparoscopic hysteromyoma removal with butorphanol

Observation of postoperative sleep quality in patients undergoing laparoscopic hysteromyoma removal with butorphanol - a prospective, randomized, double-blind, controlled clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900024590
Enrollment
Unknown
Registered
2019-07-18
Start date
2019-07-01
Completion date
Unknown
Last updated
2019-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uterine fibroids

Interventions

Group F:Postoperative PCIA electronic analgesia pump formula is 150ug/Kg butorphanol to 100ml normal saline
Group B:Postoperative PCIA electronic analgesia pump formulation is 15ug/Kg fentanyl with 100ml normal saline

Sponsors

Shenzhen Maternal and Child Health Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: ASA I-II grade, 18-55 years old, underwent laparoscopic myomectomy.

Exclusion criteria

Exclusion criteria: 1. Allergic to opioids, propofol, non-steroidal anti-inflammatory drugs, etc.; 2. A person with a history of chronic pain or mental disorders; 3. Take antidepressants, antipsychotics, sedatives, antiepileptics, and drug users within half a year; 4. Those with an operation time of more than 4 hours or a bleeding volume greater than 500 ML; 5. Patients and their families have concerns.

Design outcomes

Primary

MeasureTime frame
Sleep quality digital self-rating scale;—

Countries

China

Contacts

Public ContactXiaoli Liu

Shenzhen Maternal and Child Health Hospital

463581198@qq.com+86 13684966090

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026